31 reports

  • F. Hoffmann-La Roche
  • Vendor overview

You can easily book an appointment with one online.

  • Nanoparticle
  • Pharmaceutical
  • World
  • Market Size
  • Hoffmann-La Roche Inc.
  • MARKET SHARE

Pharmaceuticals in Europe Summary Pharmaceuticals in Europe industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial...

  • Pharmaceutical
  • F. Hoffmann-La Roche Ltd.
  • Hoffmann-La Roche Inc.
  • Johnson & Johnson
  • Novartis AG
  • MARKET SHARE

Pharmaceuticals in Scandinavia Summary Pharmaceuticals in Scandinavia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including...

  • Pharmaceutical
  • F. Hoffmann-La Roche Ltd.
  • Hoffmann-La Roche Inc.
  • Novartis AG
  • Pfizer Inc.

TABLE ##: GERMANY PHARMACEUTICALS MARKET VALUE: $ BILLION, 2013-## MARKET DATA MARKET VALUE FIGURE ##: GERMANY PHARMACEUTICALS MARKET VALUE: $ BILLION, 2013-## MARKET SEGMENTATION GEOGRAPHY SEGMENTATION Germany accounts for ##. ##% of the European

  • Pharmaceutical
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • F. Hoffmann-La Roche Ltd.
  • Hoffmann-La Roche Inc.
  • F. HOFFMANN-LA ROCHE
  • FIVE FORCES ANALYSIS

Infectious diseases and vaccines are one of the five major focus areas for Janssen Pharmaceuticals.

  • Antiviral
  • HIV Antiviral
  • Pharmaceutical
  • World
  • Hoffmann-La Roche Inc.
  • F. HOFFMANN-LA ROCHE LTD

The company operates through one business segment: human therapeutics.

  • Biotechnology
  • Pharmaceutical
  • World
  • Market Size
  • Hoffmann-La Roche Inc.
  • CANCER IMMUNOTHERAPIES DRUGS MARKET, GLOBAL, COMPANIES BY COMPOUND ANNUAL
  • 7.2.5 TABLE FOR CO-DEVELOPMENT DEALS WITH DISCLOSED DEAL VALUE

Kite Pharma Announces Positive Topline KTE-C## Data from ZUMA-## Business Wire.

  • Cancer Immunotherapy
  • Lung Cancer
  • Pharmaceutical
  • Therapy
  • Hoffmann-La Roche Inc.

Current Pharmaceutical Design; ##(##):##-##.

  • Artificial Intelligence
  • Healthcare
  • Information Technology
  • Pharmaceutical
  • Hoffmann-La Roche Inc.
  • 7.5 HOFFMANN-LA ROCHE LTD- ANALYST VIEW

Inc. is an American pharmaceutical company based in Kenilworth, New Jersey, and is amongst one of the largest pharmaceutical companies in the world.

  • Pharmaceutical
  • North America
  • United States
  • Market Size
  • Hoffmann-La Roche Inc.
  • F. HOFFMANN-LA ROCHE LTD

AstraZeneca has one business segment: biopharmaceuticals.

  • Biotechnology
  • Pharmaceutical
  • Therapy
  • AstraZeneca PLC
  • Hoffmann-La Roche Inc.
  • SCOPE OF THE REPORT

In October 2015, Seattle Genetics collaborated with Takeda Pharmaceuticals to achieve target enrollment of Phase III ECHELON-## clinical trial to evaluate ADCETRIS.

  • Pharmaceutical
  • United States
  • Forecast
  • Market Size
  • Hoffmann-La Roche Inc.
  • Vendor landscape

It is ranked as one of the top ## companies in the pharmaceuticals industry.

  • Pharmaceutical
  • United States
  • World
  • Forecast
  • Hoffmann-La Roche Inc.
  • Vendor landscape

KEY NEWS ENGERIX-B In July 2014, GSK and Isis pharmaceuticals signed a $##-million deal to develop new hepatitis B drugs.

  • Pharmaceutical
  • United States
  • World
  • Market Size
  • Hoffmann-La Roche Inc.
  • Vendor landscape
  • Market landscape

You can easily book an appointment with one online.

  • Hormones
  • Pharmaceutical
  • Hoffmann-La Roche Inc.
  • Novartis AG
  • Novo Nordisk Group
  • Vendor landscape
  • Pipeline Portfolio

You can easily book an appointment with one online.

  • Asthma
  • Pharmaceutical
  • Respiratory Treatment
  • Market Size
  • Hoffmann-La Roche Inc.
  • KEY TAKEAWAY: COMPANIES WITH A STRONG INTEGRATION OF R&D AND MARKETING ARE LIKELY TO SUCCEED
  • Vendor landscape

February 2016: OSE Pharma initiates the Atalante ## Phase III trial designed to evaluate Tedopi for the potential treatment of advanced NSCLC.

  • Lung Cancer
  • Pharmaceutical
  • Therapy
  • AstraZeneca PLC
  • Hoffmann-La Roche Inc.
  • MARKET SHARE ANALYSIS 2015
  • Vendor landscape

Opdivo Binds to PD-## on T and NKT cells.

  • Pharmaceutical
  • United States
  • World
  • Market Size
  • Hoffmann-La Roche Inc.
  • Vendor landscape
  • Scope of the report

You can easily book an appointment with one online.

  • Pharmaceutical
  • United States
  • Forecast
  • Market Size
  • Hoffmann-La Roche Inc.
  • Vendor landscape
  • Market trends

ADC is one such approach.

  • Pharmaceutical
  • Therapy
  • Amgen Inc.
  • Hoffmann-La Roche Inc.
  • Merck & Co., Inc.
  • F. HOFFMANN-LA ROCHE

Hoffmann-la Roche: Strength assessment Assessment Strength The company has a strong market presence and is one of the market leaders in the pharmaceutical industry.

  • Pharmaceutical
  • World
  • Forecast
  • Market Size
  • Hoffmann-La Roche Inc.
  • Key vendor analysis
  • Opportunities

Roche is one of the major players in the market.

  • Pharmaceutical
  • Therapy
  • Vaccine
  • World
  • Hoffmann-La Roche Inc.
  • Key vendor analysis
  • F. Hoffmann-La Roche

You can easily book an appointment with one online.

  • Pharmaceutical
  • Therapy
  • Vaccine
  • Amgen Inc.
  • Hoffmann-La Roche Inc.
  • 21.2 F. HOFFMANN-LA ROCHE
  • 20.1 COMPETITIVE SCENARIO

It is ranked as one of the top ## companies in the Pharmaceutical industry.

  • Breast Cancer
  • Pharmaceutical
  • Therapy
  • Celgene Corporation
  • Hoffmann-La Roche Inc.
  • MARKET SHARE ANALYSIS 2015
  • Vendor landscape

Opdivo Binds to PD-## on T and NKT cells.

  • Pharmaceutical
  • United States
  • World
  • Market Size
  • Hoffmann-La Roche Inc.
  • Key takeaway: Companies with a strong integration of marketing and R&D are likely to
  • KEY VENDOR ANALYSIS

ADC is one such approach.

  • Cancer
  • Monoclonal Antibody
  • Pharmaceutical
  • Therapy
  • Hoffmann-La Roche Inc.
  • Key takeaway: Companies with a strong integration of marketing and R&D is likely to succeed
  • F. HOFFMANN-LA ROCHE

You can easily book an appointment with one online.

  • Cancer
  • Monoclonal Antibody
  • Pharmaceutical
  • Therapy
  • Hoffmann-La Roche Inc.
  • Vendor landscape
  • TOP-VENDOR OFFERINGS

You can easily book an appointment with one online.

  • Pharmaceutical
  • Respiratory Treatment
  • World
  • Market Size
  • Hoffmann-La Roche Inc.
  • Vendor landscape

You can easily book an appointment with one online.

  • Pharmaceutical
  • United States
  • World
  • Market Size
  • Hoffmann-La Roche Inc.
  • CHUGAI PHARMA ENTERS INTO LICENSING AGREEMENT WITH SBI PHARMA
  • CHUGAI PHARMA ENTERS INTO LICENSING AGREEMENT WITH PHARMA MAR

Summary F.Hoffmann-La Roche Ltd (Roche) is a biotechnology company, which develops drugs and diagnostics that improve the standard of care in major disease areas. It provides pharmaceuticals in cancer, neuroscience, infection, immunology, ophthalmology, cardiovascular and metabolism, hematology, neurology and respiratory...

  • Hospital
  • Pharmaceutical
  • Therapy
  • United States
  • Hoffmann-La Roche Inc.
  • DEAL REPORT: ROCHE HOLDING ACQUIRES ANADYS PHARMACEUTICALS
  • DEAL IN BRIEF

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: Datamonitors' Hoffmann-La...

  • Pharmaceutical
  • United States
  • Company
  • Company Financials
  • Hoffmann-La Roche Inc.